Cover Image
市場調查報告書

全球血液製劑・血液檢査・血液相關裝置・人工血液製劑市場

Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment and Synthetic Blood Products

出版商 Kalorama Information 商品編碼 164667
出版日期 內容資訊 英文 225 Pages
訂單完成後即時交付
價格
Back to Top
全球血液製劑・血液檢査・血液相關裝置・人工血液製劑市場 Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment and Synthetic Blood Products
出版日期: 2014年10月10日 內容資訊: 英文 225 Pages
簡介

全球血液產業在近年來達到了大幅成長,到2017年前可望持續擴大。美國、歐洲、日本由於高齡化等各種推動因素,仍陸續引進技術開發和新產品。

本報告書為全球血液相關產品市場相關產品各類別調査分析、各產品類別的市場規模成績與2017年為止的預測、主要供應商的市場佔有率、各種市場成長影響因子、血液管理・管理・回收・加工・利用之動向、市場的主要課題、主要企業簡介等,概述如下。

第1章 總綱

第2章 概要

  • 全球血液產業
  • 血液產業歷史
  • 美國
  • 歐洲
  • 亞洲
  • 現在血液產業課題
  • 經濟影響
  • 醫療改革的變化
  • 人口統計的變化
  • 血液以及其組成
  • 免疫球蛋白
  • 輸血
  • 輸血以及相關檢査之疾病
  • 輸血相關風險
  • 對脫毒血液供給的做法
  • 人工血液製劑

第3章 血液管理系統:回收・加工・利用

  • 採血
  • 採血組織
  • 血液監測與評價
  • 透過捐助的採血方法
  • 臍帶血的採取
  • 血漿採取
  • 血型與疾病檢査
  • 血液檢査
  • 血液加工
  • 級聯血漿刻度
  • 自動刻度
  • 輸血
  • 輸血種類
  • 血液管理課題
  • 安全性上的課題 其他

第4章 血液・血液製劑市場

  • 人類血液產業推進力
  • 平均輸血費用
  • 血漿與血漿衍生物 其他

第5章 血液檢査與血型檢査市場

  • 用於捐血監測的血液檢査產品
  • 血型檢査產品
  • 血漿以及採血裝置

第6章 人工血液製劑市場

  • 人工血液製劑產業推進力
  • 替換要因的市場
  • 臨床開發之人工血液製劑
  • 其他研究領域

第7章 血液相關產品總市場

第8章 主要企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI5348440

Kalorama Information's Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products provides an analysis of all the key market segments involved in this industry, including products, equipment and testing.

There is an expanding market for human blood and blood components as a result of the growing and aging populations, particularly in the developed nations. While some countries such as India and the Philippines set prices for blood and blood components, in many of the developed nations including the U.S., there is no uniform, fixed price for blood. Rather, the cost varies from country to country and region to region, with even nearby centers often charging different prices and fluctuations often occurring.

Blood products covered in the report include:

  • Red Blood Cells (RBCs)
  • Immunoglobulins
  • Albumin
  • Other Plasma Products
  • Synthetic HBOC and PFC Agents
  • Recombinant Factors

Although the blood supplies in the developed nations are, to a very high degree, free of disease-causing viruses, the risk of transfusion-related infection is nonetheless present. Because these supplies contain human blood, achieving 100% virus eradication is unlikely. A variety of infectious agents can be present in blood, including viruses (e.g., HIV-1, hepatitis B and C, HTLV, West Nile virus), bacteria, protozoans, Chagas disease, Lyme Disease and prions (e.g., the agent of variant Crueutzfeldt-Jakob disease, which is the human form of mad cow disease). Nonetheless, blood safety is relatively high, due to the widespread usage of blood testing. As of 2014, the main residual risk is due to hepatitis B virus - ranging from 10 in Spain to 1.6 per million donations in France and Germany.

Testing markets covered include:

  • Blood Banking and Plasmapheresis Testing
  • Blood Typing
  • Human Immunodeficiency Virus (HIV) Testing
  • Hepatitis A Virus Testing
  • Hepatitis B Virus Testing
  • Hepatitis C Virus Testing
  • Human T-Cell Leukemia Virus Testing
  • West Nile Virus Testing
  • Other Safety Testing
  • High-blood-loss procedure estimates
  • Product pricing
  • Reimbursement rates
  • Products on the market and in development

The report also provides discussions of the key trends, as well as the regulatory, business, and clinical challenges facing the various sectors.

The report profiles key companies in the industry, including:

  • AABB
  • Abbott Laboratories
  • Akers Biosciences
  • America's Blood Centers
  • American Red Cross
  • Baxter International
  • Bayer AG
  • BD
  • BDI Pharma
  • Beckman Coulter
  • Beijing Tiantan Biological Products, Ltd.
  • Bharat Serums and Vaccines Ltd.
  • Bio-Rad Laboratories
  • Biotest Pharmaceuticals
  • BioTime Inc.
  • CHINA BIOLOGIC
  • CSL BEHRING
  • DiaSorin
  • Emergent Biosolutions
  • Ethicon Biosurgery
  • Fenwal/Fresenius Kabi
  • Gen-Probe Inc./Hologic
  • Grifols Biologicals, Inc.
  • HAEMONETICS, INC.
  • HUALAN BIOLOGICAL ENGINEERING
  • IMMUCOR
  • Kamada
  • Lanzhou Institute of Biological Products Nordisk
  • LFB
  • Micronics
  • Novo Nordisk A/S
  • Octapharma AG
  • OPK BioTech
  • ORTHO CLINICAL DIAGNOSTICS
  • Oxygen Biotherapeutics
  • Pfizer
  • ProMetic Biosciences
  • Reliance Life Sciences
  • Roche
  • Ronsen Pharma
  • Shanghai RAAS Blood Products Co., Ltd.
  • Shire plc
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • Sinosource Biopharmaceutical, Inc.
  • Takeda
  • Terumo BCT
  • Walvax Biotechnology Co., Ltd.

Table of Contents

ONE: Executive Summary

  • The Global Blood Industry
  • Scope and Methodology
  • Overview
  • Blood Collection
  • Blood Typing and Testing for Diseases
    • Blood Typing
    • Blood Testing
  • Blood Storage and Processing
  • Blood Transfusions
  • Blood Management and Safety Issues
  • Synthetic Blood Products
  • Blood Products Market
  • Blood Testing and Typing Products Market
  • Plasma and Blood Collection Equipment Market
  • Synthetic Blood Products Market

TWO: Overview

  • The Global Blood Industry
  • History of the Blood Industry
    • United States
    • Europe
    • Asia
  • Current Blood Industry Issues
    • Effects of the Economy
    • Changes from Health Care Reform
    • Demographic Shifts
  • Blood and Its Components
    • Red Blood Cells (Erythrocytes)
    • White Blood Cells (Leukocytes)
    • Platelets
    • Plasma
  • Immunoglobulin Products
  • Blood Transfusions
    • Diseases Contracted from Blood Transfusions and Related Identification Testing
    • Donor Deferral and Special Populations of Donors
    • Transfusion-Associated Risks
  • Efforts to Create a Virus-Free Blood Supply
    • Plasma Treatment
    • Platelet Treatments
    • Red Blood Cell Treatments
  • Synthetic Blood Products
    • Blood Volume Expanders
    • Hemoglobin-Based Oxygen Carriers
    • Immunologic Properties
    • Vasoactive Properties
    • Performance
    • Perflurocarbon (PFC)-Based Blood Products
    • Developmental Status
    • Commercialization Challenges
    • Factor Products for Hemophilia A
    • Synthetic Platelets

THREE: The Blood Management System: Blood Collection, Processing and Use

  • Blood Collection
  • Organizations Collecting Blood
    • Not-For-Profit Blood Collection
    • Red Cross
    • Community Blood Banks
    • Hospitals
    • Other Blood Collection Sites
    • For-Profit Blood Collection
    • National Donor Deferral Registry
  • Donor Donation Demographics
  • Donor Recruitment
  • Blood Screening and Evaluation
  • Methods for Collecting Blood from Donors
    • Manual Blood Collection
    • Automated Blood Collection
    • Plasmapheresis
    • Plateletpheresis
    • Leukopheresis
    • Red Blood Cell Apheresis
  • Cord Blood Collection
  • Plasma Collection
    • Plasma Fractionators
    • Distributors/Brokers
  • Blood Typing and Testing for Diseases
    • Blood Typing
    • Methods of Blood Typing
    • Manual Blood Typing Methods
    • Automated Blood Typing and Screening Methods
  • Blood Testing
    • Nucleic Acid Amplification Testing (NAT)
    • CBER Licensed NAT Screening Tests
    • Polymerase Chain Reaction (PCR) Amplification
    • CBER Licensed PCR Screening Tests
    • Immunoassay
    • Enzyme-Linked Immunosorbent Assay
    • Basic ELISA
    • Alternate ELISA Methods
    • Sandwich Method
    • Reverse Sandwich Method
    • Reverse Sandwich Inhibition Method
    • Costs and Other Barriers
    • Blood Storage
  • Blood Processing
    • Cohn Fractionation
    • Newer Fractionation Methods
    • Advanced Fractionation Methods
    • Cascade Plasma Fractionation
    • Automated Fractionation
  • Blood Transfusions
    • Testing Before Transfusion
    • Coombs Test
    • Manual Cross-Match Techniques
    • Major Cross-Match
    • Minor Cross-Match
    • Antibody Screen
  • Types of Transfusions
    • Whole Blood
    • Packed Red Blood Cells
    • Platelets
    • Leukocytes
    • Fresh Frozen Plasma (FFP)
    • Cryoprecipitate
    • Immune Serum Globulin/IMIG/IGIV
    • Factor VIII
    • Factor IX and Factor IX Complex
    • Factor VIIa
    • C1 Inhibitor
    • Fibrin/Thrombin
    • Therapeutic Apheresis
  • Blood Management Issues
    • Availability
  • Safety Issues
    • Reducing Blood Typing Errors
    • Improving Donor Screening
    • Improving Viral Screening
    • Increasing Repeat Donation Rates
    • Enhancing Viral Inactivation Processes
    • Increasing Voluntary Donation
    • Preventing Bacterial Infections
    • Biovigilance
    • Other Safety Precautions

FOUR: The Human Blood and Blood Products Market

  • Driving Forces of the Human Blood Industry
    • Variables Influencing the Demand for Blood Transfusions
    • Market Size
  • Changing Patterns of Transfusion Procedures
    • Leukocyte Reduction
    • Impact of Autologous Donations
    • Types of Autologous Donations
  • Pricing of Blood
    • National Blood Exchange
    • RBCs and Leukoreduced RBCs
    • Washed Red Blood Cells
    • Deglycerolized Red Blood Cells
    • Single-Donor Platelets and Random-Donor Platelets
    • Fresh Frozen Plasma and Pooled Frozen Plasma
    • Cryoprecipitate
    • Granulocytes
    • Gamma-Irradiated Blood
  • Average Cost of Transfusion
  • Plasma and Plasma Derived Products
    • Plasma Market Size
    • Market Dynamics
    • Immunoglobulins
    • Immunoglobulin Market Dynamics
    • Immunoglobulin Market Size
    • Hepatitis B Immunoglobulin
    • RhoD Immunoglobulin
    • Tetanus Immunoglobulin
    • Rabies Immunoglobulin
    • Varicella Immunoglobulin
    • Vaccinia Immunoglobulin
    • Neurology and Other Immunoglobulins
    • Albumin
    • Albumin Market Dynamics
    • Albumin Market Size
    • Other Products
    • Alpha-1 Proteinase Inhibitors
    • Fibrin Sealants
    • Clotting Factors, Factor VIIa and Factor VIII
    • Factor XIII
    • Total Market

FIVE: The Blood Testing and Typing Markets

  • Blood Testing Products for Donor Screening
    • Market Size
    • Immunoassays
    • Nucleic Acid Testing
    • Market Participants
    • Immunoassays
    • Nucleic Acid Testing
  • Blood Typing Products
    • Market Size
    • Market Participants
  • Plasma and Blood Collection Equipment
    • Market Size
    • Market Participants

SIX: Synthetic Blood Products Market

  • Driving Forces of the Synthetic Blood Products Industry
    • Variables Influencing the Supply and Demand of Donated Blood
  • Recombinant Factor Market
    • Market Size
    • Market Participants
  • Oxygen Carrier Market
    • Market Size
  • Synthetic Blood Products in Clinical Development
  • Hemopure (OPK BioTech)
    • Oxycyte (Oxygen Biotherapeutics)
    • Advate (Baxter)
    • Recombinant Factors
    • Stem Cell Approaches
  • Other Research Initiatives
    • Jerome H. Holland Laboratory
    • Program in Cellular and Molecular Medicine
    • National Blood Foundation

SEVEN: Total Blood Products Market

  • The Blood Products Industry
    • Market Size

EIGHT: Company Profiles

  • AABB
  • Abbott Laboratories
  • Akers Biosciences
  • America's Blood Centers
  • American Red Cross
  • Baxter International
  • Bayer AG
  • BD
  • BDI Pharma
  • Beckman Coulter
  • Beijing Tiantan Biological Products, Ltd
  • Bharat Serums and Vaccines Ltd.
  • Bio-Rad Laboratories
  • Biotest Pharmaceuticals
  • BioTime Inc.
  • CHINA BIOLOGIC
  • CSL BEHRING
  • DiaSorin
  • Emergent Biosolutions
  • Ethicon Biosurgery
  • Fenwal/Fresenius Kabi
  • Gen-Probe Inc./Hologic
  • Grifols Biologicals, Inc.
  • HAEMONETICS, INC.
  • HUALAN BIOLOGICAL ENGINEERING
  • IMMUCOR
  • Kamada
  • Lanzhou Institute of Biological Products Nordisk
  • LFB
  • Micronics
  • Novo Nordisk A/S
  • Octapharma AG
  • OPK BioTech
  • ORTHO CLINICAL DIAGNOSTICS
  • Oxygen Biotherapeutics
  • Pfizer
  • ProMetic Biosciences
  • Reliance Life Sciences
  • Roche
  • Ronsen Pharma
  • Shanghai RAAS Blood Products Co., Ltd
  • Shire plc
  • Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
  • Sinosource Biopharmaceutical, Inc.
  • Takeda
  • Terumo BCT
  • Walvax Biotechnology Co., Ltd.

LIST OF EXHIBITS

ONE: Executive Summary

  • Exhibit 1-1: Global Blood Products Market, 2013 (RBCs, Immunoglobulins, Albumin,
  • Other Plasma Products)
  • Exhibit 1-2: Total Global Market for Blood Collection Equipment: 2008 - 2018
  • Exhibit 1-3: Recombinant Factor and High Blood Loss Market: 2013 - 2018

TWO: Overview

  • Exhibit 2-1: Timeline of Global Blood Industry Development 1922 - 2014
  • Exhibit 2-2: U.S. Expectation of Life at Birth, by Sex and Race, 2014
  • Exhibit 2-3: Composition of Blood Plasma
  • Exhibit 2-4: Viral Inactivation Methods for Viruses Found in Platelets
  • Exhibit 2-5: Viral Inactivation Methods for Viruses Found in Red Blood Cells

THREE: The Blood Management System: Blood Collection, Processing and Use

  • Exhibit 3-1: Worldwide Annual Blood Collection by Component (Plasma, Platelets, Red Cells, Whole Blood)
  • Exhibit 3-2: Basic Blood Types
  • Exhibit 3-3: Blood Transfusion Compatibility
  • Exhibit 3-4: PCR-Based Screening Tests Licensed by CBER (West Nile Virus [WNV], Human Immunodeficiency Virus-1 [HIV-1], Hepatitis C Virus [HCV], Hepatitis B
  • Virus [HBV])
  • Exhibit 3-5: Comparison of Direct and Indirect ELISA Tests
  • Exhibit 3-6: Results of Cohn Fractionation Method
  • Exhibit 3-7: Plasma Proteins of Therapeutic Interest
  • Exhibit 3-8: Factor VIII Products in Development, 2014
  • Exhibit 3-9: Factor IX Products in Development, 2014
  • Exhibit 3-10: Factor VII Products in Development, 2014
  • Exhibit 3-11: Risk of Contamination
  • Exhibit 3-12: Viral Inactivation by Procedure

FOUR: The Human Blood and Blood Products Market

  • Exhibit 4-1: Geographical Distribution of RBC Demand by Region, 2013 (United
  • States, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America,
  • ROW, Total)
  • Exhibit 4-2: Projected World Demand for RBCs, 2013-2018
  • Exhibit 4-3: Worldwide Demand for RBCs for Acute and Chronic Conditions, 2013
  • Exhibit 4-4: Number of High Blood Loss Surgical Procedures by Type, 2013 (Gastrointestinal, Cardiovascular, Orthopedic, Urologic, Thoracic, Other, Total)
  • Exhibit 4-5: Average Blood and Component Requirements by Condition (Automobile Accident, Heart Surgery, Organ Transplant, Bone Marrow Transplant, Burn)
  • Exhibit 4-6: Global Blood Products Market by Type (RBCs, Immunoglobulins, Albumin, Other Plasma Products), Number of Units, Average Price and Total Value, 2013
  • Exhibit 4-7: Global Blood Collection and Transfusion Estimates, 2013-2018
  • Exhibit 4-8: Global Plasma Collection and Transfusion Estimates, 2013-2018
  • Exhibit 4-9: Countries Conducting Routine Leukocyte Reduction, 2014
  • Exhibit 4-10: Surgical Procedures Amenable to Autologous Blood Donation
  • Exhibit 4-11: CMS Blood Product Reimbursement Rates, 2014
  • Exhibit 4-12: CMS Blood Transfusion Reimbursement Rates, 2014
  • Exhibit 4-13: Selected Plasma Derived Product Approvals, 2007 - 2014
  • Exhibit 4-14: The Global Market for Plasma and Plasma Derived Products, 2008 - 2018
  • Exhibit 4-15: Selected Plasma Industry Shifts, 2003 - 2014
  • Exhibit 4-16: Sales and Market Shares of Leading Suppliers of Plasma and Plasma Derived Products, 2013
  • Exhibit 4-17: Global Market for Immunoglobulins by Manufacturer, 2013 - 2018
  • Exhibit 4-18: Global Market for Human Albumin Products by Brand, 2013 - 2018
  • Exhibit 4-19: Global Market for Other Plasma Products, 2013 - 2018
  • Exhibit 4-20: Prevalence of Conditions Requiring Prothrombin Complex Concentrates
  • Exhibit 4-21: Leading Factor IX Products, 2014
  • Exhibit 4-22: Global Market for Other Plasma Products, 2013 - 2018 (RBCs, Immunoglobulins, Albumin, Other Products, Total)
  • Exhibit 4-23: Geographical Distribution of Human Plasma Products, 2013 (United States, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW, Total)

FIVE: The Blood Testing and Typing Markets

  • Exhibit 5-1: Total Global Market for Immunoassay versus Nucleic Acid Testing
  • Equipment, 2008 - 2018
  • Exhibit 5-2: Geographical Distribution for Immunoassay versus Nucleic Acid Testing Equipment, 2013 (United States, Germany, UK, France, Spain, Japan,
  • China, Other Asia, Latin America, ROW, Total)
  • Exhibit 5-3: Global Blood Banking and Plasmapheresis Testing by Molecular
  • Diagnostics, 2013 - 2018 (HIV, HCV, HBV, HAV, HTLV, WNV, Others, Total)
  • Exhibit 5-4: U.S. Blood Banking and Plasmapheresis Testing by Molecular
  • Diagnostics, 2013 - 2018 (HIV, HCV, HBV, HAV, HTLV, WNV, Others, Total)
  • Exhibit 5-5: Global Projected Blood Banking and Plasmapheresis Molecular
  • Diagnostics Testing Market Potential, 2013 - 2018 (HIV, HCV, HBV, HAV, HTLV, WNV, Others, Total)
  • Exhibit 5-6: Projected Blood Banking and Plasmapheresis Molecular Diagnostics Testing Market Potential in the United States, 2013 - 2018 (HIV, HCV, HBV, HAV, HTLV, WNV, Others, Total)
  • Exhibit 5-7: Geographical Distribution for Blood Banking and Plasmapheresis
  • Molecular Diagnostics, 2013 (United States, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW, Total)
  • Exhibit 5-8: Selected Commercially Available Molecular (Nucleic Acid) Tests for Blood, Plasma and Organ Donor Screening in the United States, 2005 - 2014
  • Exhibit 5-9: Sales and Market Shares of Leading Suppliers of Blood Testing
  • Products for Donor Screening, 2013
  • Exhibit 5-10: Total Global Market for Blood Typing Equipment, 2008 - 2018
  • Exhibit 5-11: Geographical Distribution for Blood Typing Equipment, 2013 (United
  • States, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America,
  • ROW, Total)
  • Exhibit 5-12: Sales and Market Shares of Leading Suppliers of Blood Typing
  • Equipment, 2013
  • Exhibit 5-13: Total Global Market for Blood Collection Equipment, 2008 - 2018
  • Exhibit 5-14: Geographical Distribution for Blood Collection Equipment, 2013 (United States, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW, Total)
  • Exhibit 5-15: Global Market for Automated Blood Collection Equipment, 2008 - 2018
  • Exhibit 5-16: Geographical Distribution for Automated Blood Collection Equipment, 2013 (United States, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW, Total)
  • Exhibit 5-17: Sales and Market Shares of Leading Suppliers of Blood Collection Equipment, 2013

SIX: Synthetic Blood Products Market

  • Exhibit 6-1: World Recombinant Factor Market by Brand, 2012 - 2018
  • Exhibit 6-2: Geographical Distribution for World Recombinant Factor Market, 2013 (United States, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW, Total)
  • Exhibit 6-3: High Blood Loss Market HBOC and PFC Agent Revenues,
  • 2013 - 2018
  • Exhibit 6-4: Leading Recombinant Factor Products in Clinical Trials, 2014

SEVEN: Total Blood Products Market

  • Exhibit 7-1: Global Blood Products Market by Segment, 2013
  • Exhibit 7-2: Total Global Blood Products Market Forecast by Segment, 2013 - 2018(RBCs and Other Plasma Products, Recombinant Factors, Immunoglobulins, Blood
  • Collection Equipment, Molecular Diagnostic Tests, Albumin, Blood Typing Reagents and Instruments, HBOCs and PFCs, Total)
  • Exhibit 7-3: Global Blood Products Market by Segment, 2018
  • Exhibit 7-4: Total Global Blood Products Market by Region, 2013
  • Exhibit 7-5: Global Blood Products Market Forecast by Segment and Region, 2013 (United States; Germany; UK; France; Spain; Japan; China; Other Asia; Latin America; ROW; Total; RBCs, Immunoglobulins, Albumin and Other Plasma Products; Recombinant Factors; Blood Collection Equipment; Molecular Diagnostic
  • Tests; Blood Typing Reagents and Instruments; Total)
  • Exhibit 7-6: Global Blood Products Market by Segment and Region, 2013
  • Exhibit 7-7: Global Blood Products Market by Region and Segment, 2013
  • Exhibit 7-8: Sales and Market Shares of Leading Suppliers of Plasma and Plasma Derived Products, 2013

EIGHT: Company Profiles

  • Exhibit 8-1: Key Global, National and Regional Blood Industry Players, 2013
Back to Top